Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct 3:8:266.
doi: 10.3389/fendo.2017.00266. eCollection 2017.

Associations between Systemic Sclerosis and Thyroid Diseases

Affiliations
Review

Associations between Systemic Sclerosis and Thyroid Diseases

Poupak Fallahi et al. Front Endocrinol (Lausanne). .

Abstract

We have reviewed scientific literature about the association of systemic sclerosis (SSc) and thyroid disorders. A high incidence, and prevalence, of new cases of autoimmune thyroiditis (AT) and/or hypothyroidism have been shown in sclerodermic patients (overall in the female gender). An association among a Th1 immune-predominance, low vitamin D levels, and AT have been also shown in SSc patients. Cases of Graves' disease (GD) have been described in SSc patients, too, according with the higher prevalence of thyroid autoimmunity. It has been also shown a higher prevalence of papillary thyroid cancer (PTC), in association with AT, in SSc patients. However, in order to confirm results about GD and thyroid cancer, studies in larger number of patients with SSc are needed. During the follow-up of SSc patients it would be appropriate to monitor carefully their thyroid status. The abovementioned data strongly suggest a periodic thyroid function follow-up in female SSc patients [showing a borderline high (although in the normal range) thyroid-stimulating hormone level, antithyroid peroxidase antibody positivity, and a small thyroid with a hypoechoic pattern], and, when necessary, appropriate treatments. In conclusion, most of the studies show an association among SSc, AT, and hypothyroidism, such as an increased prevalence of TC overall in SSc patients with AT. Only few cases of GD have been also described in SSc.

Keywords: CXCL10; Graves’ disease; antithyroglobulin antibodies; antithyroperoxidase antibodies; autoimmune thyroiditis; hypothyroidism; systemic sclerosis; thyroid cancer.

PubMed Disclaimer

References

    1. Ferri C, Sebastiani M, Lo Monaco A, Iudici M, Giuggioli D, Furini F, et al. Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients’ population and review of the literature. Autoimmun Rev (2014) 13:1026–34.10.1016/j.autrev.2014.08.029 - DOI - PubMed
    1. Barsotti S, Stagnaro C, d’Ascanio A, Della Rossa A. One year in review 2016: a systemic sclerosis. Clin Exp Rheumatol (2016) 34(Suppl 100):3–13. - PubMed
    1. Giuggioli D, Lumetti F, Colaci M, Fallahi P, Antonelli A, Ferri C. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature. Autoimmun Rev (2015) 14:1072–8.10.1016/j.autrev.2015.07.008 - DOI - PubMed
    1. Dowson C, Simpson N, Duffy L, O’Reilly S. Innate immunity in systemic sclerosis. Curr Rheumatol Rep (2017) 19:2.10.1007/s11926-017-0630-3 - DOI - PubMed
    1. Jimenez SA, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med (2004) 140:37–50.10.7326/0003-4819-140-2-200401200-00013 - DOI - PubMed

LinkOut - more resources